CP 154526

CP 154526 Suppliers list
Company Name: 3B Pharmachem (Wuhan) International Co.,Ltd.  
Tel: 18930552037
Email: 3bsc@sina.com
Company Name: LETOPHARM LIMITED  
Tel: +86-21-5821 5861
Email: sales@letopharm.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: Jinan Jiuli Biotechnology Co. , Ltd.  
Tel: 15865264761
Email: 486064515@qq.com
Company Name: TargetMol Chemicals Inc.  
Tel: 4008200310 15002144251
Email: marketing@tsbiochem.com

CP 154526 manufacturers

  • CP 154,526
  • CP 154,526 pictures
  • $2380.00
  • 2026-04-21
  • CAS:157286-86-7
  • Purity:
  • Supply Ability: 10g
CP 154526 Basic information
Product Name:CP 154526
Synonyms:N-Butyl-N-ethyl-2,5-dimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine;7H-Pyrrolo[2,3-d]pyrimidin-4-amine,N-butyl-N-ethyl-2,5-dimethyl-7-(2,4,6-trimethylphenyl)-;N-butyl-N-ethyl-2,5-dimethyl-7-(2,4,6-trimethylphenyl)pyrrolo[2,3-d]pyrimidin-4-amine;CP-154,526;N-Butyl-N-ethyl-2,5-dimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-aminehydrochloride;CP 154;CP154;CP-154
CAS:157286-86-7
MF:C23H32N4
MW:364.53
EINECS:
Product Categories:Amines;Aromatics;Heterocycles;Intermediates & Fine Chemicals;Neurochemicals;Pfizer Compounds;Pharmaceuticals
Mol File:157286-86-7.mol
CP 154526 Structure
CP 154526 Chemical Properties
Boiling point 423.5±45.0 °C(Predicted)
density 1.06
storage temp. Desiccate at +4°C
pka6.97±0.30(Predicted)
Safety Information
MSDS Information
CP 154526 Usage And Synthesis
UsesA selective, non-peptide antagonist of corticotropin releasing factor receptors (CRF1). It blocks CRF-induced adenylate cyclase activation and attenuates activation of the HPA axis by CRF. It displayed anxiolytic-like activity in the rat elevated plus-maze test; brain penetrant.
Biological ActivitySelective, non-peptide CRF 1 receptor antagonist (K i values are 2.7 and > 10000 nM for CRF 1 and CRF 2 receptors respectively). Blocks CRF-induced adenylate cyclase activation (K i = 3.7 nM) and attenuates activation of the HPA axis by CRF. Displays anxiolytic-like activity in the rat elevated plus-maze test; brain penetrant.
in vivo

CP 154526 (1-10 mg/kg; i.p.; once) exhibits signs of anxiolytic-like activity in the elevated plus-maze test in rats[2].

Animal Model:Male Sprague Dawley rats[2]
Dosage:1 mg/kg, 3 mg/kg, 10 mg/kg
Administration:i.p.; once
Result:Exhibited signs of anxiolytic-like activity.
CP 154526 Preparation Products And Raw materials
Tag:CP 154526(157286-86-7) Related Product Information
4-(N-Ethyl-N-4-hydroxybutyl)amino-2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)pyrrolo[2,3-d]pyrimidine hydrochloride CP 154526 AURORA KA-7509 Antalarmin hydrochloride JNJ-19567470 Antalarmin hydrochloride